A Study of INCB059872 and INCB057643 in Relapsed or Refractory Ewing Sarcoma

Conditions:   Relapsed Ewing Sarcoma;   Refractory Ewing Sarcoma Interventions:   Drug: INCB059872;   Drug: INCB057643 Sponsor:   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials